Literature DB >> 19331133

Adhesion/growth-regulatory tissue lectin galectin-1 in relation to angiogenesis/lymphocyte infiltration and prognostic relevance of stromal up-regulation in laryngeal carcinomas.

Sven Saussez1, Christine Decaestecker, Stéphanie Cludts, Perle Ernoux, Dominique Chevalier, Karel Smetana, Sabine André, Xavier Leroy, Hans-Joachim Gabius.   

Abstract

BACKGROUND: Galectin-1 has been found to modulate lymphocyte invasion in inflammation and to be involved in angiogenesis in models, thus prompting examination of its clinical relevance in laryngeal cancer. PATIENTS AND METHODS: Immunohistochemical processing of tissue sections (n=53) from patients with stage I/II (n=35) and stage IV (n=18) laryngeal squamous cell carcinoma (LSCC) with a specific anti-galectin-1 antibody and monitoring of CD45/CD31 positivity was combined with quantitative morphometric analysis.
RESULTS: Lectin presence in the tumor and endothelial cells was positively correlated, while a negative relationship to the number of CD45-positive lymphocytes was demonstrated. No association was seen with the extent of neovascularization. The mean optical density (MOD) of lectin-dependent staining in the tumor stroma was significantly increased compared to normal stroma.
CONCLUSION: Galectin-1 was not associated with angiogenesis in the studied cohort while galectin-1 in endothelial cells may negatively influence lymphocyte invasion and the mean optical density for the stromal galectin-1 signal is up-regulated in tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19331133

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Anti-human embryonic stem cell monoclonal antibody Hesca-2 binds to a glycan epitope commonly found on carcinomas.

Authors:  Mohamed G Shoreibah; Crystal L Jackson; Paul W Price; Richard Meagher; Andrew K Godwin; Qi Cai; Jeffrey C Gildersleeve
Journal:  Stem Cells Dev       Date:  2010-11-08       Impact factor: 3.272

Review 2.  Unraveling How Tumor-Derived Galectins Contribute to Anti-Cancer Immunity Failure.

Authors:  Diego José Laderach; Daniel Compagno
Journal:  Cancers (Basel)       Date:  2021-09-09       Impact factor: 6.575

3.  Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer.

Authors:  Jie Chen; Su-Jun Zhou; Yun Zhang; Guo-Qiang Zhang; Tian-Zhou Zha; Yi-Zhong Feng; Kai Zhang
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

4.  Galectin-1 mediates TGF-β-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer.

Authors:  Lingyan Zheng; Cong Xu; Zhonghai Guan; Xingyun Su; Zhenzhen Xu; Jiang Cao; Lisong Teng
Journal:  Am J Transl Res       Date:  2016-04-15       Impact factor: 4.060

Review 5.  Role of tumor microenvironment in tumorigenesis.

Authors:  Maonan Wang; Jingzhou Zhao; Lishen Zhang; Fang Wei; Yu Lian; Yingfeng Wu; Zhaojian Gong; Shanshan Zhang; Jianda Zhou; Ke Cao; Xiayu Li; Wei Xiong; Guiyuan Li; Zhaoyang Zeng; Can Guo
Journal:  J Cancer       Date:  2017-02-25       Impact factor: 4.207

Review 6.  The Impact of Obesity, Adipose Tissue, and Tumor Microenvironment on Macrophage Polarization and Metastasis.

Authors:  Ola Habanjar; Mona Diab-Assaf; Florence Caldefie-Chezet; Laetitia Delort
Journal:  Biology (Basel)       Date:  2022-02-21

7.  Galectin-1 is a diagnostic marker involved in thyroid cancer progression.

Authors:  Vanessa Arcolia; Fabrice Journe; Aurore Wattier; Emmanuelle Leteurtre; Florence Renaud; Hans-Joachim Gabius; Myriam Remmelink; Christine Decaestecker; Alexandra Rodriguez; Sébastien Boutry; Sophie Laurent; Sven Saussez
Journal:  Int J Oncol       Date:  2017-07-04       Impact factor: 5.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.